Sorrento Therapeutics, Inc.
Methods for Treating Parkinson?s Disease by Administering Resiniferatoxin

Abstract:

There is disclosed a method for treating Parkinson's Disease (PD) comprising administering an effective amount of Resiniferatoxin (RTX) by an intrathecal or intracisternal administration. In some embodiments, the dose of RTX for an adult human is from about 0.1 .mu.g to about 100 .mu.g.